Singapore to create animals with human DNA
By DPA,
DPA
| 01. 09. 2008
Scientists eager to splice human genes with animal cells are seeking a public feedback on the prospect of such controversial research, the Bioethics Advisory Committee (BAC) said on Wednesday.
A consultation paper on its website said the BAC considers human stem cell research to have considerable potential in the treatment of currently incurable diseases, such as diabetes, Alzheimer's disease and Parkinson's disease.
"While there have been significant advances in stem cell science and technology, research involving human-animal combinations is required for further progress," the BAC said.
Professor Lim Pin, BAC chairperson, said scientists overwhelmingly want to conduct research in a way that is ethical.
Those favouring such research maintain it could be vital to finding cures to many human diseases. Mice with human brain cells could be used as test beds for Parkinson's disease or Alzheimer's disease drugs, they said.
The city-state, with its ambitions to become a global bio-medical powerhouse, has the technology to create these "mixed animals" that can be created by infusing a human nucleus, the cell's nerve centre, with an animal egg or cell, Lim said...
Related Articles
By Carissa Wong, New Scientist | 07.08.2026
Healthy lambs have been born via an experimental form of in vitro fertilisation (IVF) that coaxes highly immature eggs to become mature ones in the lab. This is the first time the approach has been demonstrated in a large animal...
By Maggie Astor, The New York Times | 06.23.2026
Every year, patients undergo millions of in vitro fertilization procedures worldwide. Only a minority result in a live birth.
In an effort to improve the odds, scientists have developed an array of “add-ons” that could in theory identify the most...
By Carl Zimmer and Catrin Einhorn, The New York Times | 06.25.2026
The Trump administration and a company that is promising to bring long-gone animals back from extinction announced a partnership on Thursday to preserve cells, tissue and DNA from threatened and endangered species.
The company, Colossal Biosciences, said its goal was...
By Julianna LeMieux, Genetic Engineering & Biotechnology News | 04.14.2026
Twenty years ago, Sven Bocklandt, PhD, sought to create a hypoallergenic cat. He had the genetic engineering chops to do it, but the embryology was beyond his capabilities. At a small animal genetic engineering conference, known as TARC (Transgenic Animal...